Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	9.59	8.42	7.69
Graham Fair Price	19.17	52.10	43.72
PEG	8685.84	0.12	< 0.005
Price/Book	18.02	2.97	2.52
Price/Cash Flow	1.33	9.74	9.61
Prices/Earnings	11.41	2.45	2.20
Price/Sales	14.53	5.60	4.89
Price/FCF	1.33	9.74	9.61
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.14	0.78	0.76
Operating Margin	5.41	0.65	0.62
ROA	3.30	0.19	0.19
ROE	0.29	0.30	5.94
ROIC	0.22	0.24	9.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	-0.06	-72.21
Dividends QOQ	0.01	< 0.005	-77.49
EBIT QOQ	21.65	0.24	-98.88
EPS QOQ	16.79	0.21	-98.73
FCF QOQ	82.49	0.33	-99.60
Revenue QOQ	2.73	0.18	-93.46
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	89.49	93.61	4.60
Days Sales Outstanding (DSO)	40.71	42.73	4.95
Inventory Turnover	1.01	0.96	-4.40
Debt/Capitalization	0.20	0.19	-9.04
Quick Ratio	3.38	2.88	-14.99
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	17.24	19.96	15.78
Cash	10.42	12.77	22.51
Capex	-0.10	-0.15	-47.10
Free Cash Flow	4.51	6.08	34.85
Revenue	8.87	10.58	19.31
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.17	3.53	-15.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.26	0.21	-20.74
Naive Interpretation	Member

06 - Financial Health · Bad

Rating